Inovio announces the appointment of michael cordera as executive vice president & general counsel

Plymouth meeting, pa., march 15, 2021 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on bringing to market precisely designed dna medicines to treat and protect people from infectious diseases and cancer, today announced the appointment of michael cordera as executive vice president and general counsel.
INO Ratings Summary
INO Quant Ranking